Roly Foulkes

Company: Revolo Biotherapeutics

Job title: Chief Medical Officer

Seminars:

ClinicalLeveraging IRL201104, a Tolerogenic Molecule that Induces Treg & Breg Activation to Restore Immune Homeostasis in Patients with Allergies 2:00 pm

Investigating IRL2011104 – antigen presenting cell binding pathways to effector cell and inflammatory cytokine regulation  Targeting ‘upstream’ antigen presenting cells to restore homeostasis and enhance remission outcomes Showcasing clinical successes to inform Phase 2b IV studiesRead more

day: Day 2 Treg Modulators Track PM

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
[email protected]

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.